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The identity of the glucose transporters (GLUT) expressed in neurons in situ has yet to be fully established. In the present study we have isolated 
the GLUT3 (RGT3) cDNA and produced anti RGT3 polyclonal antibody allowing usto investigate the cellular localization and tissue distributions 
of RGT3 mRNA and protein in the central nervous system of the rat by the methods of in situ hybridization and immunohistochemistry. Here 
we demonstrate the direct evidence that RGT3 is present in neurons in adult rat brain. In situ hybridization showed the expression of RGT3 mRNA 
mostly in the regions of hippocampus, cerebral cortex, striatum, and the granule cell layer of the cerebellum, indicating that RGT3 mRNA is 
predominantly expressed within neurons. Immunohistochemistry showed that RGT3 protein is widely distributed in the rat brain, and concentrated 
on the plasma membrane of neurons. Double labeling studies with anti-RGT3, glial fibrillary acidic protein (GFAP), and neuron specific enolase 
(NSE) antibodies revealed the specific expression of RGT3 protein in neurons. Thus, RGT3 is indicated to be a neuron specific glucose transporter 
isoform (NSGT), and suggested to play a functionally significant role in rat central neurons. 
Glucose transporter; GLUT3; Neuron specific enolase (NSE); Glial fibrillary acidic protein (GFAP) 
1. INTRODUCTION 
Since the brain cannot store the significant levels of 
carbohydrate, maintenance of normal cerebral func- 
tions is almost exclusively dependent on a sustained 
supply of glucose from the blood [1,2]. Glucose, being 
a polar substance, crosses lipid bilayers of cell mem- 
branes [3] by a saturable and stereospecific nonenergy 
dependent process of facilitated diffusion system [4], 
which consists of a family of closely related membrane 
associated glycoprotein termed the glucose trans- 
porters; GLUTl-GLUT4 [5]; GLUT5 has recently 
been shown to be a fructose transporter [6]. 
In the central nervous system, glucose transport is 
mediated by a facilitative diffusion type transport sys- 
tem [7,8,9], and suggested to be regulated at two levels. 
First, glucose is transported across the blood brain bar- 
rier (anatomically consisting of contiguous brain capil- 
lary endothelial cells jointed by zonula occludens type 
tight junctions [lo]) from the circulation into the brain’s 
extracellular space. Once in the extracellular space, glu- 
cose is then transported intracellularly into both neu- 
ronal and glial cells by a similar carrier-mediated proc- 
ess. GLUT1 is concentrated in cells of blood-brain bar- 
rier, which indicates the general role for this transporter 
isoform is the transport of glucose from the blood into 
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the underlying tissue layers [11,12,13]. On the other 
hand, the identity of the glucose transporter expressed 
specifically in neurons has yet to be fully established. 
Although GLUT1 mRNA and protein can be shown to 
be present in primary cultures of neonatal neuronal cells 
[ 14,151, the expression of GLUT1 in these cells might be 
due to the cultural conditions. In fact, it has not been 
possible to show expression of GLUT1 in neuronal cells 
in situ except the expression in the Purkinje cells of only 
mouse cerebellum (unpublished results), which indi- 
cates that another glucose transporter isoform is re- 
sponsible for glucose transport in neuronal cells. In hu- 
mans, GLUT3 mRNA is expressed at highest level in 
the brain, but, present at variable levels in all tissues and 
tumors [16,17]. Mantych et al. [18] showed that human 
GLUT3 protein was present in neuropils and microvas- 
cular endothelial cells in human brain, but they could 
not demonstrate the definite exhibition of GLUT3 pro- 
tein in neuronal cells. In contrast to the tissue distribu- 
tion of human GLUT3 mRNA, mouse GLUT3 
mRNA, which we have recently cloned from mouse 
brain [19], was only present at high levels in the brain, 
suggesting mouse GLUT3 being a neuronal glucose 
transporter. 
In this study we have isolated a cDNA clone from rat 
brain encoding a rat glucose transporter protein 
(GLUT3), and produced antibodies using multiple anti- 
gen peptide (MAP) of COOH-terminal 17 amino acids 
of rat GLUT3 (RGT3). Thereby we could have taken 
advantages of a powerful approach combining in situ 
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hybridization and immunohistochemistry to determine 
the protein localization in expressing neurons. Here, we 
demonstrate that RGT3 protein is localized on the 
plasma membrane of rat neurons in situ. Double label- 
ing studies with using neuronal (neuron-specific eno- 
lase; NSE) and astrocytic (glial fibrillary acidic protein; 
GFAP) markers revealed the specific expression of 
RGT3 in neurons. Thus, we propose rodent GLUT3 as 
a neuron specific glucose transporter (NSGT). 
PAKET) or human GLUT1 (SQSDKTPEELFHPL) were also syn- 
thesized. MAP of RGT3 was emulsified with complete Freund’s ad- 
juvant and injected into rabbits using standard procedures for antise- 
rum production. Rabbits were boosted by a subcutaneous injection of 
the antigen emulsified in incomplete Freund’s adjuvant. 
2.4. Immunoblot analysis 
2. MATERIALS AND METHODS 
2.1. cDNA cloning 
The rat GLUT3 cDNA was isolated from a rat hippocampus ;IgtlO 
cDNA library (Clontech) using a portion of the previously described 
mouse GLUT3 sequence as probe [19]. The probe was a 563 base pair 
(bp), radiolabeled with [‘*P]dCTP by nick translation. Hybridization 
conditions consisted of 50% formamide, 5 x SSC, 1 x Denhardt’s olu- 
tion, 0.1% SDS, salmon sperm at 100 pg/ml, and probe (lo6 cpm/ml) 
at 42°C. Final wash conditions were 0.1 x SSC. 0.1% SDS at 55°C. 
Purified pharge clones were subcloned into pGEM4G (Promega, Bio- 
tech). DNA sequence analysis was performed by the dideoxynucleo- 
tide chain termination procedure [20] using synthetic oligonucleotide 
primers. and Sequenase 2.0 (US Biochemical) after ligation to 
M13mp18. or -19. 
The whole brain or different organs of the rat were homogenized 
in 5 ml of a solution of 40 mM Tris-HCI (pH 7.4), 2 mM EDTA, 250 
mM Sucrose, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1% 
Triton X-100, mixed with Laemmli sampling solution. Westerns were 
performed essentially as previously described [191. Approximately 50- 
100 fig of proteins was subjected to 10% SDS-polyacrylamide gel 
electrophoresis (PAGE), and electrophoretically transferred to nitro- 
cellulose. The filters were blocked with 5% non-fat milk in 10 mM 
Tris-buffered saline (TBS), pH 7.4, at 37°C for 1 h followed by incu- 
bation for 3 h at room temperature with I:500 dilutions of the primary 
antiserum. Filters were washed with TBS containing 0.05% Tween 20. 
Immunoreactive bands were visualized by alkaline phosphatase-cou- 
pled goat anti-rabbit IgG secondary antibody (Dako), using substrates 
Nitroblue tetrozolium and 5-bromo-4-chloro-3-indolyl-phosphate 
(Wako Ind. Ltd.). For competition analysis, each peptide of RGT3, 
human GLUT3, or human GLUT1 was preincubated with the diluted 
primary antiserum for 30 min prior to incubation with filter. 
2.5. Immunohistochemistr~ 
2.2. In situ hybridization hrstochemistr) 
Brains from adult male Wistar rats were removed immediately after 
killing, embedded in OCT compound (Tissue Tek Inc.) in the liquid 
nitrogen, and stored at -80°C until sectioning. Ten-pm sagittal sec- 
tions were cut at -20°C and collected throughout he brain. Sections 
were then air-dried, washed with 0.1 M Phosphate buffered saline 
(PBS), fixed with 4% paraformaldehyde, and quenched with 2 mg/ml 
of glycine. Sections were digested with 1 @ml of protease K and 
pre-hybridized with 50% (v/v) deionized formamide/ x SSC at 42°C 
for 30 min. Digoxygenin-labeled sense and antisense riboprobes were 
prepared by transcription of plasmids coding for rat GLUT3 using T7 
or SP6 RNA polymerase as described in the manual of RNA labeling 
kit (Boehringer Mannheim). The cDNA inserts m the plasmid, cloned 
in pGEM4G (Promega Biotec), encodes amino acids 207-394 of rat 
GLUT3. Slides were hybridized for a 16 h at 42°C in a 100~1 solution 
of 20 mM Tris-HCl (pH 7.4). 2.5 mM EDTA, 1 x Denhardt’s olution, 
300 mM NaCl. 0.5 mg/ml yeast tRNA, 50% formamide and 50--100 
fig/ml antisense or sense digoxygenin labeled riboprobes. After wash- 
ing the slides with 50% formamide and 2 x SSC for 30 min at 45°C 
and rinsing with 10 mM Tris-HCI (pH 7.4) and 500 mM NaCI, they 
were treated with 2O@ml boiled RNase A solution in the same buffer 
for 1 h at room temperature. Slides were then washed twice with 50% 
formamidel2 x SSC for 30 min at room temperature. To detect the 
signals, slides were washed twice with 50 mM Tris-HCI (pH 8.0). 150 
mM NaCl and incubated with 1:500 dilution of anti-digoxygenin Fab 
fragment conjugated with alkaline phosphatase for 1 h at room tem- 
perature. After washing the slides three times with 50 mM Tris-HC1 
(pH 8.0), 150 mM NaCI, they were rinsed with 100 mM Tris-HCI @H 
9.0). 100 mM NaCI, and 5 mM MgCI,. The color was developed with 
the incubation of Nitroblue tetrazohum (NBT) and 5-bromo-4- 
chloro-3-indolyl phosphate (BCIP) m a dark box. The reaction was 
stopped with TE buffer (10 mM Tris-HC1 (pH 8.0). 1 mM EDTA), 
and slides were mounted in gelatimglycine solution, then observed 
with light microscopy. 
Adult rats were sacrificed by ether anesthesia nd decapitation, and 
dissected brains were fixed with 4% paraformaldehyde in0.1 M phos- 
phate buffer (PB). The paraffin embedded tissues were cut into 5 pm 
and deparaffinized with xylene and rehydrated with 0.05 M Tris-HC1 
(pH 7.4) and 0.15 M NaCl in 100% ethanol. They were incubated with 
0.3% H202 before treatment with 10% normal goat serum to reduce 
a non-specific binding. Tissue sections were reacted with a I:500 dilu- 
tion of RGT3 antiserum for 1 h at 37°C in TBS. The immunohisto- 
chemical staining was performed according to the avidin-biotin perox- 
idase (Dako, Denmark) method of Hsu [22]. The peroxidase reaction 
was done with 3,3’-diaminobenzidine t trachloride (DAB; Nakarai 
tesque), which produces the brown color. Certain brain sections were 
double labeled with RGT3 antiserum (1:500 dilution) tagged with a 
biotinylated anti-rabbit second antibody (Dako, Denmark) and anti- 
neuron-specific enolase (NSE) antiserum (1: 1000 dilution; a gift from 
Dr. I. Takeshita, Kyushu University, Japan). a marker for neuronal 
cells [23325]; or an anti-glial fibrillary acidic protein antiserum 
(GFAP; 1:lOOO dilution; a gift from Dr. M. Fukui, Kyushu University, 
Japan), a marker for astrocyte [26,27], tagged with an ALP conjugated 
anti-rabbit second antibody. In cases where the biotinylated second 
antibody was employed, after the primary RGT3 antiserum incuba- 
tion, sections were treated with a biotinylated goat anti-rabbit IgG for 
40 mm, followed by incubation with the avidin-biotin-peroxidase com- 
plex for another 30 min and, finally, with 3’,3’-diaminobenzidine (a 
brown color-producing reagent). The slides were then incubated with 
5% acetic acid for 3 h to remove the excess of RGT3 antiserum, and 
were incubated with 1:lOOO diluted solution of anti-NSE or GFAP 
antisera for 1 h at RT. After the sections were incubated with anti- 
rabbit IgG conjugated with alkaline phosphatase (ALP) (1:500 dilu- 
tion), ALP reaction was done using a Naphtol AS-MX phosphate 
(Sigma) and a Fast blue BB base (Wako Ind.) (a blue color-producing 
reagent). Thus, RGT3 was stained brown, NSE and GFAP were 
stained blue. 
3. RESULTS 
Multiple antigen peptide (MAP) containing the 17 amino acid 
(GVELNSMQPVKETPGNA) carboxy-terminus of the rat GLUT3 
protein was synthesized on an Applied Biosystem model 430A peptide 
synthesizer basically by the method of Tam [21]. Peptides of COOH- 
terminal amino acids of the human GLUT3 (KDGVMEMNSIE- 
2.3. Antibody production 3.1. Isolation and sequence of rat GLUT3 cDNA clones 
Initially, three clones were isolated from a rat brain 
cDNA library by high-stringency hybridization condi- 
tions with a 563 base pair (bp) cDNA fragment of 
mouse GLUT3. The sequences of two clones indicated 
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that they encoded RGT3, a protein homologous to 
mouse GLUT3 or human GLUT3. These clones con- 
tain the complete protein-coding region, the 5’ and 3 
untranslated region of the mRNA (Fig. 1). The se- 
quences of these clones agreed in overlapping regions, 
showing them to be derived from the same mRNA. 
RGT3 is composed of 493 amino acids and has - 94% 
and - 82% identity to the sequences of mouse GLUT3 
[19] and human GLUT3 [16], respectively. Like the 
other facilitated glucose transporters, hydropathic and 
secondary structure analyses of RGT3 suggest he pres- 
ence of 12 hydrophobic transmembrane domains with 
a predominantly a-helical secondary structure, an ex- 
tracellular loop between Ml and M2 with a potential 
N-glycosylation sites, and a large intracellular hydro- 
phobic loop in the center of the protein. Although data 
are not shown, RNA blotting studies revealed that the 
RGT3 cDNA probe hybridized to a single transcript of 
- 4.0 kb in the cerebrum, cerebellum, and brainstem of 
rat brain, and RGT3 mRNA was only present in the rat 
brain as well as the results of mouse GLUT3 [19]. 
3.2, Cellular localization of rat GLUT3 mRiVA in brain 
In situ hybridization (ISH) was used to examine the 
patterns of expression of RGT3 genes in brain. Hybrid- 
ization of a digoxigenine-labeled complementary (anti- 
sense) RNA probe for RGT3 mRNA to brain sections 
showed that GLUT3 mRNA was expressed in substan- 
tial parts of brain with relatively high levels in the hip- 
s 
B - 
Fig. 2. Distribution of RGT3 mRNA in adult rat brain analyzed by 
in situ hyb~d~tion. Sagittal sections of adult rat brain were hybrid- 
ized to digoxigenine labeled antisense or sense strand RNA probes for 
RGT3 mRNA, as shown in A or B, respectively. Note that RGT3 
mRNA is present in most parts of the brain with highest levels in the 
cortex (Cx), hippocampus (HP), striatum (St), and cerebellum (Cb), 
but is at low abundance in the brainstem. An adjustant sagittal section 
hybridized to RGT3 sense probe as a control (B) shows the extent of 
nonspecific hybridization. C represents a localization of ISH signals 
of RGT3 mRNA in cerebellum. ISH of thecerebellum cortex, showing 
dense RGT3 signai diffusely overlying the granuie cell layer(G). Other 
u~~~e~j~~~o~~~ M, molecular cell layer; W, white matter of the cerebel- 
lum. 
pocampus, dentate gyrus, cerebral cortex, striatum, and 
cerebellum (Fig. 2). RGT3 mRNA expression was also 
observed in the brainstem with low levels. Fig. 2C shows 
ISH in the cerebellum at higher magnification. Most 
hybridization signals were observed in the granule cell 
layer of cerebellum. 
3.3. Characterization of RGT3 spe@c antibodies 
Specific polyclonal rabbit antibodies were raised to 
RGT3 protein by immunization with multiple antigen 
291 
Volume 334, number 3 
1 2 3 4 
80 - 
- - 
49.5 - 
~1 ; 
32.5 - 1 --a ," 
rrr, P.E % Li 
November 1993 
5 3.4. Immunohistochemical iocalization of rat GL UT3 in 
80 - 
49.5 - - 
w 
32.5 - 
Fig. 3. Characterization of RGT3 protein by immunoblot. (A) Tissue 
lysates from a whole adult rat brain (50 pg of protein per lane) were 
separated by SDS 10% polyacrylamide gel electrophoresis and im- 
munoblotted with a rabbit polyclonal antibody to amino acids 4777 
493 of RGT3 protein, m the absence (lane 1) or presence (lane 2) of 
excess of the immunizing peptide. An excess of synthetic peptides of 
C-terminal regions of human GLUT3 or human GLUT1 was also 
added in lane 4 or lane 5, respectively. Antibody binding was detected 
using an alkaline phosphatase-~nju~t~ secondary antibody. RGT3 
was recognized as a single band of - 60 kDa. Lane 3 shows the im- 
munoreactivity of the rat brain proteins with preimmune serum. (B) 
Tissue lysates from several rat organs and a mouse brain (150 pg of 
protein per lane) were immunoblotted with RGT3 antiserum. Note 
that the immunoreactive band from a mouse brain was migrated at 
- 50 kDa, in contrast to a single band of - 60 kDa of RGT3. The 
mobilities of prestained molecular mass markers (size noted in kilodal- 
ton) are shown to the left. Abbreviations: MB, mouse brain; RB, rat 
brain; He, heart; Li, liver; K, kidney. 
peptides (MAP) deduced from C-terminal coding region 
generating the specific antiserum. This peptide antise- 
rum s~cifically recognizes the appropriate rat or mouse 
GLUT3 proteins in an immunoblot (Fig. 3). The anti- 
body reacted with rat or mouse whole brain lysates of 
values of - 60 and - 50 kDa on SDS-polyacrylamide lec- 
trophoresis, respectively. Since the protein sequence of 
C-terminal coding region of RGT3 protein used in the 
synthetic peptide was exactly same as mouse GLUT3 
protein, the antibody reacted with both proteins. Al- 
though these size estimates are slightly ‘different from 
the predicted molecular mass values of 53,488 Da for 
mouse [19] and 53,566 Da for rat, this may be due to 
either the mobility on SDS-PAGE or the glycosylation. 
As well as the result of tissue distribution by RNA 
blotting study (data not shown}, the antibody recog- 
nized the protein only in the brain. Preimmune serum 
did not react with glucose transporter proteins, and 
absorption of this antiserum with the immunizing pep- 
tide completely inhibited its binding. Addition of syn- 
thetic peptides of C-terminal coding regions of human 
GLUT3 protein (KDGVMEMNSIEPAKET) or 
human GLUT1 protein (SQSDKTPEELFHPL) did 
not inhibit the binding of this antiserum to RGT3 pro- 
tein. Taken together, these results suggest that this an- 
tiserum specifically recognizes GLUT3 protein in ro- 
dent. 
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The distribution of RGT3 protein in the rat brain as 
revealed by antibody labeling is shown in Fig. 4. The 
immunoreactivity was present in most parts of the 
brain. Strong signals were observed in lateral habenular 
nucleus, amygdaloid nucleus, oculomotor nucleus, and 
red nucleus (Fig. 4A and B). Labeling of many nucle- 
uses in the brainstem was noted with greater intensities 
in the raphe pontine nucleus, pontine reticular nuclei V, 
trigeminal nucleus, lateral superior olive, nucleus of 
trapezoid body, mesencephalic trigeminal nucleus (Fig. 
4C). In the cerebellum, RGT3 immunoreactivities were 
found in the greatest concentration in the granule cell 
layer and white matter of the cerebellum, but was absent 
from molecular cell layer (Fig. 4D). This is in excellent 
agreement with ISH of cerebellum, which shows that 
the granule cell layer contains the higher levels of RGT3 
mRNA, while the molecular cell layer lacks hybridiza- 
tion signals (see Fig. 2C). 
3.5. RGT3 is neuron s~ec~~~ 
Analyses of 3 pm sections using light microscopy 
demonstrated that RGT3 immunoreactivity was clearly 
present on the cell surface membrane of neuronal cell 
bodies and fine processes (Fig. 5A). Immunoreactive 
neurons showed strong plasma membrane labeling of 
neuronal cell bodies and dendrites. Staining was absent 
from the nuclei and cytoplasm of immunoreactive cells. 
Fig. SB shows the neurons in brainstem double-stained 
for the RGT3 and for the neuron-specific enolase (NSE) 
antigen. The plasma membrane of neuronal cell body, 
whose cytoplasmic segment was stained for the NSE 
antibody, was also stained for the RGT3 antibody. Fig. 
5C shows double-stained for the RGT3 and for the glial 
fibrillary acidic protein (GFAP) antigen. The sequence 
of the plasma membrane of neuronal cell body not 
stained for the GFAP antibody were stained the RGT3 
antibody. 
4. DISCUSSION 
In spite of an important role of glucose metabolism 
in neurons, the presence of glucose transporter proteins 
in neurons in situ has not yet been shown clearly. Since 
mouse GLUT3 is predo~nantly expresses in brain as 
shown in previous studies [19,28], it was suggested that 
mouse GLUT3 is a neuronai glucose transporter, how- 
ever, we and others did not show the direct evidence of 
the presence of GLUT3 protein in neurons in situ. The 
present study is the first to demonstrate the distribution 
of glucose transporter protein (GLUT3) expressed in 
neurons. 
In this study, we isolated the cDNA clone encoding 
RGT3, which indicates that it is a protein of 493 amino 
acids and that it has - 94% and - 82% identity to the 
sequences of mouse GLUT3 and human GLUT3, re- 
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Fig. 4. RGT3 immunoreactivities in coronal sections of rat brain. A 
series of photomicrographic image shows the overall distribution of 
RGT3 protein in coronal sections of the rat brain (A,B,C). (D) Immu- 
nohist~hemist~ of cerebellum at higher ma~cation, showing 
dense RGT3 staining localized to the granule cell (G) layer, and the 
white matter (W) of the cerebellar cortex, and to a lesser degree in the 
Purkinje cells (PC). Abbreviations: CC, corpus callosum; Hp, hip- 
pocampus; Cx, cortex; LH, lateral habenular nucleus; An, amygdaloid 
nucleus: Mm, mammillo thalamic tract; IC, internal capsule; Opt, 
optic tract; On, oculomotor nucleus; SC, superior colliculus; Rn, red 
nucleus: WM, white matter of cerebellum; RP, raphe pontine nucleus; 
PR, pontine reticular nuclear V, Tn, trigeminal nucleus; LS, lateral 
superior olive; TB, trapezoid body; MT, mesencephalic trigeminal 
nucleus. 
spectively. The sequence of GLUT3 is highly conserved 
between mouse and rat, but is not highly conserved 
between human and rodent. In contrast to the tissue 
distribution of human GLUT3 mRNA which is present 
at variable levels in all human tissue [ 16,291, expressions 
of RGT3 mRNA and protein are restricted to the brain 
as well as to the mouse as previously shown [19,30]. 
Thus, not only the amino acid sequence but also the 
tissue distribution pattern are highly conserved between 
mouse and rat GLUT3, suggesting that rodent GLUT3 
is a neuron-s~cific glucose transporter. ISH revealed 
that RGT3 mRNA was expressed at relatively high lev- 
els in the hippocampus, dentate gyrus, cerebral cortex, 
striatum, cerebellum, and to a lesser degree in the brain- 
stem, which is almost similar to mouse GLUT3 mRNA 
expression pattern, as previously shown somewhere 
[19]. The major difference between mouse and rat was 
observed in the region of cerebellum, where mouse 
GLUT3 mRNA was predominantly expressed in the 
Purkinje cell layer, whereas RGT3 mRNA was ob- 
served mostly in the granule cell layer. Physiological 
meanings of such a species difference are unknown at 
present. 
I~unohistoche~stry is a powerful tool for the pur- 
pose of addressing the question of whether RGT3 is 
present only in neurons or distributed widely in cells 
other than neurons (e.g. astrocyte, oligodendrocyte, or 
endothelial cells of blood brain barrier, etc.), while clar- 
ifying the localization of RGT3 protein in the rat brain. 
In order to produce an anti-RGT3-specific antibody 
allowing us to do immunohistochemical studies, we syn- 
thesized the multiple antigen peptide (MAP) of 17 
amino acids (477-493) of RGT3 by the method of Tam 
[21], and immunized rabbits. RGT3 antiserum pro- 
duced by MAP was specific for rat GLUT3 proteins by 
following reasons. (1) Preimmune serum did not react 
with rat whole brain lysates. (2) * 60 kD immunoreactive 
band was absorbed with the preincubation of 100 &ml 
of immunizing peptide. (3) Synthetic peptides of 
COOH-terminal regions of human GLUT3 or human 
GLUT1 did not inhibit the binding of this antibody to 
RGT3 protein. In fact, in rodent brain the human 
GLUT3 synthetic peptide antibody do not crossreact 
with the rodent GLUT3 band [29]. (4) Tissue distribu- 
tion of RGT3 protein agreed with the result of RNA 
blotting. Thus, this antibody enabled us to study the 
dist~bution of RGT3 proteins in rat central nervous 
system (CNS). 
The RGT3 protein distributions in CNS were very 
extensive, but not ubiquitous, with detectable expres- 
sion throughout each major subdivision of the brain. 
The results of i~unohistochemist~ in several differ- 
ent parts of the rat brain argue that RGT3 protein is 
localized on the plasma membrane of neurons. Al- 
though the staining densities of RGT3 proteins were not 
parallel to the levels of RGT3 mRNAs revealed by ISH, 
the pattern of the distribution correlated roughly with 
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Fig. 5. Immunolocalization of RGT3 in neurons from the rat brain. (A) In 3 pm sections of brainstem, RGT3 immunoreactivity is localized to 
the plasma membrane (Pm) of neurons (arrows) and to dendrites (arrowheads). (B) Immunodetection of NSE antigen (which labels the cytoplasm 
(Cy) within neuron) and RGT3 by double-staining technique on the same section as in (A). NSE staining is shown by blue-color, and RGT3 shown 
by brown, (N = nucleus) (C) Immunodetecdon of GFAP antigen (which labels the glial cells (G)) and RGT3 on the same section as in (A). GFAP 
c 
staining is shown by blue-color, and RGT3 shown by brown. 
each other. In the cerebellum, ISH showed that RGT3 
mRNA was heavily concentrated in the granule cell 
layer of cerebellar cortex, but was not found in the 
molecular layer and the white matter of cerebellum. On 
the other hand, RGT3 i~unoreactivity was detected 
in the granule cell layer and the white matter of cerebel- 
lum, but not in the molecular layer where the axons 
(parallel fibers) of the granule cells are packed. Taken 
together the results of ISH and immunohistochemistry 
in the cerebellum, it is suggested that RGT3 protein is 
synthesized in the granule cells, and is concentrated in 
the neuronal somata. 
To directly demonstrate that RGT3 protein is present 
in neurons, double-stained technique was carried out 
with the neuron-s~~ifi~ enolase (NSE) and the glial 
fibrillary acidic protein (GFAP) antibodies, which are 
the cell markers of neurons [23-251 and glias [26,27], 
respectively. RGT3 immunoreactivity could be detected 
only in the neuron in which the cytoplasm was stained 
with NSE. The y subunit of enolase (y-enolase), desig- 
nated neuron-specific enolase (NSE), is distributed 
widely in other than neuronal and neuroendocrine cells 
[31,32]; though, at least in normal brain, NSE is ex- 
pressed only in neurons. The results thus demonstrate 
that RGT3 protein is specifically expressed in neurons, 
but not in glias or blood-brain barriers in brain. 
In conclusion, we have cloned rat GLUT3 glucose 
transporter cDNA and produced specific antibody 
using multiple antigen peptide (MAP), thereby we have 
visualized the distribution and localization of RGT3 
mRNA and protein by ISH and immunohistochemis- 
try. The examinations of combined ISH and immu- 
nohistochemistry identified RGT3 as a neuron-specific 
glucose transporter. Further investigation of expression 
or distribution of RGT3 mRNA and protein under dif- 
ferent conditions would provide additional information 
about the significance of the glucose transporter system 
in physiological and patholo~~al functions in the CNS. 
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